The forkhead/winged-helix Foxa family of transcription factors, encoded by three genes Foxa1 (Hnf3␣), Foxa2 (Hnf3), and Foxa3 (Hnf3␥), regulate hepatic and/or pancreatic gene expression (1-9). Foxa1 and Foxa3 are required for maintaining glucose homeostasis by activation, respectively, of pancreatic glucagon and hepatic gluconeogenic enzymes (2, 3, 5). Targeted disruption of Foxa2 resulted in embryonic lethality with defective development of the foregut endoderm, from which the liver and pancreas arise (10). Foxa2, which is expressed in islets, has been suggested as the upstream transactivator of Hnf4␣, Hnf1␣, Pdx1, and Hnf1 in the transcriptional hierarchy (1, 9, 11). Mutations in the genes encoding these pancreatic transcription factors are linked to four monogenic forms of MODY 1 (maturity-onset diabetes of the young): MODY1/HNF4␣, MODY3/HNF1␣, MODY4/IPF1(PDX1), and MODY5/HNF1 (12, 13). However, the search for the association of FOXA2 mutations with MODY patients has not been successful (14, 15). Most recently, Sund et al. (16) have suggested that FOXA2 rather might be a candidate gene for familial hyperinsulinism. Pancreatic -cell-specific deletion of Foxa2 resulted in postnatal death due to severe hyperinsulinemic hypoglycemia, and the down-regulation of ATP-sensitive K ϩ (K ATP ) channel subunits Sur1 and Kir6.2 has been demonstrated in these mutant mice (16).To assess whether Foxa2 indeed controls the expression of the transcription factors associated with MODY, we have established INS-1-derived stable cell lines, which allow conditional expression of the wild type Foxa2 or its dominant-negative mutant DN-Foxa2 under tight control of the reverse tetracycline-dependent transactivator (17). DN-Foxa2 is a Myctagged truncated Foxa2 mutant protein that possesses the intact DNA-binding domain but lacks the transactivation domain (7). DN-Foxa2 exerts its dominant-negative function by competing with the endogenous Foxa2 for cognate DNA binding (7). The impact of altered Foxa2 function on glucose metabolism and insulin secretion was assessed in these stable clones. The gene expression profile before and after induction of the Foxa2 or DN-Foxa2 was quantified.
EXPERIMENTAL PROCEDURESEstablishment of Stable Cell Lines-Rat insulinoma INS-1 cell linederived stable clones were cultured in RPMI 1640 in 11.2 mM glucose (18), unless otherwise indicated. The first step stable clone INSr␣, which expresses the reverse tetracycline-dependent transactivator, was described previously (17,18). Plasmids used in the secondary stable transfection were constructed by subcloning the cDNAs encoding the mouse Foxa2 (kindly supplied by Prof. G. Schü tz) and its dominantnegative mutant (DN-Foxa2) into the expression vector PUHD10 -3 (a kind gift from Prof. H. Bujard). DN-Foxa2 (truncated mutation lacking the transactivation domain but containing the intact DNA-binding domain) (7) was PCR-amplified from Foxa2 cDNA using the following primers: 5Ј-gcaggatccgtaatggtgctcgggcttcaggtg-3Ј and 5Ј-gcaggatccggcgccatggcgggcatgagcggctca3-Ј. The ...